Ligand Binding Domain Activating Mutations of ESR1 Rewire Cellular Metabolism of Breast Cancer Cells

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1505
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Unraveling the Clinicopathological Features Driving the Emergence of ESR1 Mutations in Metastatic Breast Cancer

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2018English

Free Fatty Acids Rewire Cancer Metabolism in Obesity-Associated Breast Cancer via Estrogen Receptor and mTOR Signaling

Cancer Research
Cancer ResearchOncology
2019English

Sertad1 Promotes Prostate Cancer Progression Through Binding Androgen Receptor Ligand Binding Domain

International Journal of Cancer
Cancer ResearchOncology
2018English

Phosphoinositide 3-Kinase Mutations in Breast Cancer: A "Good" Activating Mutation?

Clinical Cancer Research
Cancer ResearchOncology
2009English

Cellular Retinoic Acid Binding Protein and Breast Cancer

2004English

Kinetics, Prognostic and Predictive Values of ESR1 Circulating Mutations in Metastatic Breast Cancer Patients Progressing on Aromatase Inhibitor

Oncotarget
Oncology
2016English

Involvement of Ras GTPase-activating Protein SH3 Domain-Binding Protein 1 in the Epithelial-To-Mesenchymal Transition-Induced Metastasis of Breast Cancer Cells via the Smad Signaling Pathway

Oncotarget
Oncology
2015English

18f-Fluoroestradiol Positron Emission Tomography Imaging of Activating Estrogen Receptor Alpha Mutations in Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy